Expanding pharmacists' role for patients with hypertension could prevent 15 million heart attacks and save $1.1 trillion

The article discusses a study led by Virginia Commonwealth University, which found that granting pharmacists greater authority to prescribe blood pressure medications could have a significant impact on public health and the economy. If pharmacists were to take a more active role in managing hypertension, the study estimates that over 30 years, more than 15 million heart attacks and 8 million strokes could be prevented in the United States. Additionally, this could lead to the prevention of millions of cases of angina and heart failure, showcasing the potential health benefits of such a policy change.

The economic implications of the study are equally substantial, with projected savings to the U.S. healthcare system of over $1.1 trillion within the same timeframe. This equates to an average cost saving of $10,162 per patient. Beyond the financial benefits, the study suggests that patients could enjoy an increase in quality-adjusted life years—a measure of both the quantity and the quality of life. This indicates that patients would not only live longer but would also have better health and well-being during those years.

The research underscores the potential for pharmacists to fill a critical gap in healthcare, especially given the current shortage of primary care providers in the U.S. With most Americans living within five miles of a pharmacy, pharmacists are in a unique position to provide accessible care. However, the study also points out the legislative barriers that currently limit pharmacists' ability to be reimbursed for clinical services, suggesting that policy changes could enable pharmacists to contribute more effectively to patient care and help mitigate the rising rates of hypertension-related health issues.